You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Graft-vs-Host Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Graft Vs. Host Disease Trial (INCA34176)

Available
  • Chronic Graft Vs. Host Disease
  • (no location specified)
Sep 14, 2022

Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

Active, not recruiting
  • Chronic Graft vs Host Disease
  • Chronic Graft-Versus-Host Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 29, 2022

Clinical and Biological Factors Determining Outcomes in Chronic

Recruiting
  • Chronic Graft vs Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

    Recruiting
    • Chronic Graft vs Host Disease
    • Regulatory T-cell enriched infusion
    • Sevilla, Spain
      José Antonio Pérez Simón
    May 20, 2022

    Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute

    Recruiting
    • Chronic Graft vs Host Disease
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Patients at Risk for Chronic Graft-Versus-Host Disease

    Not yet recruiting
    • cGVHD
    • Non-Interventional
    • (no location specified)
    Jun 16, 2023

    Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))

    Recruiting
    • Mesenchymal Stem Cells
    • Mesenchymal Stem Cells (MSCs)
    • Shapingba, Chongqing, China
      Xinqiao Hospital
    Nov 24, 2023

    Hematological Malignancies Trial in Durham (fostamatinib)

    Active, not recruiting
    • Hematological Malignancies
    • Durham, North Carolina
      Duke University of Medicine
    Jul 14, 2022

    Chronic GVHD Trial in United States (drug, procedure, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • Tampa, Florida
    • +4 more
    Aug 10, 2023

    Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)

    Recruiting
    • Chronic Graft-Versus-Host Disease
    • Allogeneic Stem Cell Transplant
    • App
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 24, 2023

    GVHD Trial in Worldwide (INC424)

    Active, not recruiting
    • Graft vs Host Disease
    • Sao Paulo, Brazil
    • +20 more
    Oct 26, 2022

    Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • Atlanta, Georgia
      Northside Hospital
    Sep 21, 2023

    Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

    Not yet recruiting
    • Chronic Graft-versus-Host-Disease
    • +4 more
      • (no location specified)
      Jan 11, 2023

      Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

      Recruiting
      • Chronic Graft vs Host Disease
        • Bucheon-Si, Korea, Republic of
        • +9 more
        Jan 27, 2023

        Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

        Recruiting
        • Chronic Graft Versus Host Disease
        • Duarte, California
          City of Hope Site Number : 8400001
        Nov 23, 2023

        Chronic GVHD Trial in Bethesda, Saint Louis (Ibrutinib)

        Recruiting
        • Chronic GVHD
        • Bethesda, Maryland
        • +1 more
        Jan 26, 2023

        Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention

        Recruiting
        • Graft Vs Host Disease
        • +2 more
        • Exercise
        • Attention control
        • Boston, Massachusetts
        • +1 more
        Nov 28, 2022

        Chronic GVHD Trial in United States (Ofatumumab)

        Completed
        Has Results
        • Chronic Graft Versus Host Disease
        • Phoenix, Arizona
        • +3 more
        Sep 30, 2022

        Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

        Recruiting
        • Chronic Graft Versus Host Disease
        • Steroid Refractory Graft Versus Host Disease
        • Duarte, California
          City of Hope Medical Center
        Sep 14, 2022

        Chronic GVHD Trial in Duarte (biological, procedure, other)

        Active, not recruiting
        • Chronic Graft Versus Host Disease
        • Aldesleukin
        • +3 more
        • Duarte, California
          City of Hope Medical Center
        Jan 4, 2023

        Mapping for Detection of Chronic Lung Injury in Hematopoietic

        Recruiting
        • Chronic Lung Disease
        • +2 more
          • Ann Arbor, Michigan
            The University of Michigan Cancer Center
          May 9, 2023

          Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical

          Recruiting
          • Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
          • topical ruxolitinib 1.5% cream
          • Topical vehicle/moisturizer cream
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Dec 20, 2022

          Chronic GVHD Trial (Belumosudil)

          Not yet recruiting
          • Chronic Graft Versus Host Disease
          • (no location specified)
          Jan 5, 2023

          GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

          Terminated
          Has Results
          • Graft Versus Host Disease
          • +2 more
          • Ruxolitinib 1.5% cream
          • vehicle cream
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jun 21, 2022

          Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

          Active, not recruiting
          • Chronic Graft-versus-host-disease
          • Salt Lake City, Utah
            Huntsman Cancer Institute at University of Utah
          Jan 30, 2023